SPV-30 boxwood evergreen tree extract slows HIV/AIDS progress in two studies.
This article was originally published in The Tan Sheet
Executive Summary
BOXWOOD EVERGREEN TREE EXTRACT SLOWS HIV/AIDS PROGRESS IN TWO STUDIES presented at the XI International Conference on AIDS in Vancouver, one a clinical trial conducted in France, and the other an "informal" six-month study enrolling 400 subjects in the U.S. The proprietary standardized extract is marketed in France by Arkopharma under the product name SPV-30 and distributed in the U.S. by the Health Connection, based in Jericho, N.Y.